Key result
This article is an editorial announcing the winners of the 2023 Eberhard F. Mammen Young Investigator Awards in thrombosis and hemostasis.
Key points are not available for this paper at this time.
Design
Editorial
Announcement of the 2023 Eberhard F. Mammen Young Investigator Awards in thrombosis and hemostasis.
Welcome to the latest of our Eberhard F. Mammen Award announcements. As noted many times previously, Thieme, the publisher of Seminars in Thrombosis & Hemostasis (STH), has created the “ Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards” in honor of Eberhard Mammen ([ Fig. 1 ]) and in recognition of his contribution to this field and to the journal that he both founded and steered for over three decades (see [ Table 1 ] for relevant references). These awards began in 2009, under two categories; the current award details and conditions are as follows: Table 1 Listing of relevant editorials published in Seminars in Thrombosis and Hemostasis as related to the initiation of the Eberhard F. Mammen Awards, as well as previous award announcements 1. Favaloro EJ. Welcome to a Special Issue of Seminars in Thrombosis and Hemostasis—the closing issue for 2008. Semin Thromb Hemost 2008;34(8):693–696 2. Favaloro EJ. A Tribute to Eberhard F. Mammen, M.D. (1930–2008). Semin Thromb Hemost 2008;34(8):703–708 3. Favaloro EJ. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009. Semin Thromb Hemost 2009; 35(1):1–2. 4. Favaloro EJ. Winners of the Inaugural Eberhard F. Mammen Award for most popular article. Semin Thromb Hemost 2009;35(7):587–590 5. Favaloro EJ. 2009 Eberhard F. Mammen Young Investigator Award winners. Semin Thromb Hemost 2010;36(5):469–470 6. Favaloro EJ. Winners of the 2010 Eberhard F. Mammen Award for most popular article during 2008-2009. Semin Thromb Hemost. 2010;36(7):685–692. 7. Favaloro EJ. 2011 Eberhard F. Mammen Award announcements. Semin Thromb Hemost. 2011;37(5):431–439. 8. Favaloro EJ. 2012 Eberhard F. Mammen Award announcements. Semin Thromb Hemost. 2012;38(5):425–432. 9. Favaloro EJ. 2013 Eberhard F. Mammen Award announcements. Semin Thromb Hemost. 39(6):567–574. 10. Favaloro EJ. 2014 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2014;40(4):407–412. 11. Favaloro EJ. 2014 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost. 2014;40(7):718–723. 12. Favaloro EJ. 2015 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2015;41(7):673–679. 13. Favaloro EJ. 2015 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost. 2015;41(8):809–815. 14. Favaloro EJ. 2016 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2016;42(4):325–330. 15. Favaloro EJ. 2016 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost. 2017;43(3):235–241. 16. Favaloro EJ. 2017 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2017;43(4):357–363. 17. Favaloro EJ. 2017 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost. 2018;44(2):81–88. 18. Favaloro EJ. 2018 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2018;44(3):185–192. 19. Favaloro EJ. 2018 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost. 2019;45(2):123–129. 20. Favaloro EJ. 2019 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2019;45(3):215–224. 21. Favaloro EJ. 2019 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost 2020;46(2):105–113 22. Favaloro EJ. 2020 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2020;46(4):383–392. 23. Favaloro EJ. 2020 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost 2021;47(3):229–237. 24. Favaloro EJ. 2021 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2021;47(5):467–476. 25. Favaloro EJ. 2021 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost. 2022;48(3):265–273. 26. Favaloro EJ. 2022 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2022;48(5):502–513. 27. Favaloro EJ. 2022 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost. 2023;49(8):775–782. 28. 2023 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2023;49(5):417–426. 29. Favaloro EJ. 2024 Eberhard F. Mammen Award announcements: part I-most popular articles. Semin Thromb Hemost. 2024:10.1055/s-0044-1782197. Fig. 1 Eberhard F. Mammen (1930–2008). Most popular article awards: awarded to the authors of the most popular articles published in STH in the preceding 2 years as captured in the preceding year. The awards are determined by the Editor in Chief on the basis of user statistics from Thieme e-Journals. Prefaces, Errata, Letters to the Editor, Editorials, Commentaries, and previous award-winning articles are excluded from further consideration of these awards, which currently comprise two categories—one for “Free Access” articles and another for a “General Category.” There are two major cash prizes of US$1,000 for each category. In addition, winners of the “General Category” awards are granted “Free Access” status for these articles thereafter. Young Investigator Awards: best presentation or meeting abstract by a young investigator—as presented or delivered to an international or large regional meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr Mammen. Up to six cash prizes of US$1,000 in any year. There are some additional considerations and conditions for the award, and awardees are expected to prepare a review or other paper related to the topic of their presentation (or as otherwise agreed) for publication in STH. In general, previous award winners are excluded from a second award to enable more individuals to be recognized. After nominations are received, the awardees are selected by a vote of the Senior Editors of STH. Any potential conflicts of interest are managed by first identifying these and then excluding those with potential conflicts from voting. Finally, given the increased potential of virtual meetings, virtual presentations can also be considered for the award. Further details of the awards and the award winners are posted online ( https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 ), and previous award winner announcements are also available in print (see [ Table 1 ] for a listing of relevant editorials published in this journal as related to the initiation of the Eberhard F. Mammen Awards, as well as previous award announcements; these publications are also available for free download from the journal website: https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 ). The winners of the 2023 Eberhard F. Mammen Awards for the most popular articles from STH for the period of 2020 to 2021 inclusive were announced in an earlier issue of the journal,[ 1 ] as were the 2024 Eberhard F. Mammen Awards for the most popular articles from STH for the period of 2022 to 2023 inclusive.[ 2 ] It is therefore with great pleasure that we would like to announce the winners of the latest round of Young Investigator Awards. As mentioned above, the Young Investigator Awards represent winners of the best presentation or meeting abstract by a young investigator—as presented or delivered to an international or large regional meeting (virtual meetings permissible) on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr Mammen. There are additional considerations, given that the nominees' presentations are not necessarily seen by all of the possible award nominators, being drawn from the broader editorial team of the journal as well as potentially from outside the editorial team, nor necessarily seen by all the voting team (comprising the senior editors of the journal). The latest winners are identified below, with a running list of previous awardees, and the resulting publications in the journal, given in [ Table 2 ]. The latest awardees derived from recent meetings of the International Society on Thrombosis and Haemostasis (ISTH), the American Society for Hematology (ASH), the International Society for Fibrinolysis & Proteolysis (ISFP), the European Congress in Thrombosis and Haemostasis, and a recent Blood Scientific Meeting (representing a combined meeting of the Haematology Society of Australia and New Zealand, the Australian and New Zealand Society of Blood Transfusion, and the Thrombosis and Haemostasis society of Australia and New Zealand [THANZ]). Table 2 Publications arising from previous Eberhard F. Mammen Young Investigator award winners[ a ] Awardee Year awarded Publication arising Willem M. Lijfering 2009 Lijfering WM, Flinterman LE, Vandenbroucke JP, Rosendaal FR, Cannegieter SC. Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. Semin Thromb Hemost. 2011;37(8):885–896. Salley Pels 2009 Pels SG. Current therapies in primary immune thrombocytopenia. Semin Thromb Hemost. 2011;37(6):621–630. Adam Cuker 2010 Cuker A. Current and emerging therapeutics for heparin-induced thrombocytopenia. Semin Thromb Hemost. 2012;38(1):31–37. Giridhara Rao Jayandharan 2010 Jayandharan GR, Srivastava A, Srivastava A. Role of molecular genetics in hemophilia: from diagnosis to therapy. Semin Thromb Hemost. 2012;38(1):64–78. Timea Szanto 2010 Szántó T, Joutsi-Korhonen L, Deckmyn H, Lassila R. New insights into von Willebrand disease and platelet function. Semin Thromb Hemost. 2012;38(1):55–63. Birgitta Salmela 2010 Salmela B, Joutsi-Korhonen L, Armstrong E, Lassila R. Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysis. Semin Thromb Hemost. 2012;38(1):23–30. Pia Riittaa-Maria Siljander 2010 Aatonen M, Grönholm M, Siljander PR. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin Thromb Hemost. 2012;38(1):102–113. Romaric Lacroix 2011 Lacroix R, Dignat-George F. Microparticles: new protagonists in pericellular and intravascular proteolysis. Semin Thromb Hemost. 2013;39(1):33–39. Brad McEwen 2011 McEwen BJ, Morel-Kopp MC, Chen W, Tofler GH, Ward CM. Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease. Semin Thromb Hemost. 2013;39(1):25–32. Neil A. Goldenberg 2011 Bernard TJ, Armstrong-Wells J, Goldenberg NA. The institution-based prospective inception cohort study: design, implementation, and quality assurance in pediatric thrombosis and stroke research. Semin Thromb Hemost. 2013;39(1):10–14. Vivien Chen 2011 Chen VM. Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange. Semin Thromb Hemost. 2013;39(1):40–47. Joseph E. Italiano, Jr. 2011 Italiano JE Jr. Unraveling mechanisms that control platelet production. Semin Thromb Hemost. 2013;39(1):15–24. Vivian Xiaoyan Du 2012/2013 Du VX, Huskens D, Maas C, Al Dieri R, de Groot PG, de Laat B. New insights into the role of erythrocytes in thrombus formation. Semin Thromb Hemost. 2014;40(1):72–80. Andrew Yee 2012/2013 Yee A, Kretz CA. Von Willebrand factor: form for function. Semin Thromb Hemost. 2014;40(1):17–27. Sarah O'Brien 2012/2013 O'Brien SH. Contraception-related venous thromboembolism in adolescents. Semin Thromb Hemost. 2014;40(1):66–71. Veronica Flood 2012/2013 Flood VH. Perils, problems, and progress in laboratory diagnosis of von Willebrand disease. Semin Thromb Hemost. 2014;40(1):41–48. Julie Tange 2012/2013 Tange JI, Grill D, Koch CD, Ybabez RJ, Krekelberg BJ, Fylling KA, Wiese CR, Baumann NA, Block DR, Karon BS, Chen D, Pruthi RK. Local verification and assignment of mean normal prothrombin time and international sensitivity index values across various instruments: recent experience and outcome from North America. Semin Thromb Hemost. 2014;40(1):115–120. Kent Chapman 2012/2013 Chapman K, Yuen S. Therapy for thrombotic thrombocytopenia purpura: past, present, and future. Semin Thromb Hemost. 2014;40(1):34–40. Andreas Tiede 2014 Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014;40(7):803–811. Wendy Lim 2014 Lim W. Thrombotic risk in the antiphospholipid syndrome. Semin Thromb Hemost. 2014;40(7):741–746. Susana Nobre Fernandes 2014 Fernandes S, Carvalho M, Lopes M, Araújo F. Impact of an individualized prophylaxis approach on young adults with severe hemophilia. Semin Thromb Hemost. 2014;40(7):785–789. Maria Elisa Mancuso 2014 Mancuso ME, Fasulo MR. Thrombin generation assay as a laboratory monitoring tool during by-passing therapy in patients with hemophilia and inhibitors. Semin Thromb Hemost. 2016;42(1):30–35. Coen Maas 2014 Tersteeg C, Fijnheer R, Deforche L, Pasterkamp G, de Groot PG, Vanhoorelbeke K, de Maat S, Maas C. Keeping von Willebrand factor under control: alternatives for ADAMTS13. Semin Thromb Hemost. 2016;42(1):9–17. Riten Kumar 2014 Kumar R, Dunn A, Carcao M. Changing paradigm of hemophilia management: extended half-life factor concentrates and gene therapy. Semin Thromb Hemost. 2016;42(1):18–29. Juraj Sokol 2015 Sokol J, Skerenova M, Jedinakova Z, Simurda T, Skornova I, Stasko J, Kubisz P. Progress in the understanding of sticky platelet syndrome. Semin Thromb Hemost 2017;43(1):8–13 Ljubica Jovanović 2015 Jovanovic L, Antonijevic N, Novakovic T, Savic N, Terzic B, Zivkovic I, Radovanovic N, Asanin M. Practical aspects of monitoring of antiplatelet therapy. Semin Thromb Hemost 2017;43(1):14–23 Lucia Stanciakova 2015 Stanciakova L, Dobrotova M, Jedinakova Z, Duraj L, Skornova I, Korinkova L, Holly P, Danko J, Stasko J, Kubisz P. Monitoring of hemostasis and management of anticoagulant thromboprophylaxis in pregnant women with increased risk of fetal loss. Semin Thromb Hemost. 2016;42(6):612–621. Tina Biss 2015 Biss TT. Venous thromboembolism in children: is it preventable? Semin Thromb Hemost. 2016;42(6):603–611. Tobias Fuchs 2015 Jiménez-Alcázar M, Kim N, Fuchs TA. Circulating extracellular DNA: cause or consequence of thrombosis? Semin Thromb Hemost. 2017;43(6):553–561 Jonathan M. Coutinho 2015 Silvis SM, Middeldorp S, Zuurbier SM, Cannegieter SC, Coutinho JM. Risk factors for cerebral venous thrombosis. Semin Thromb Hemost. 2016;42(6):622–631. Soundarya Selvam 2016 Selvam S, James P. Angiodysplasia in von Willebrand disease: understanding the clinical and basic science. Semin Thromb Hemost. 2017 Sep;43(6):572–580. Vincent Muczynski 2016 Muczynski V, Christophe OD, Denis CV, Lenting PJ. Emerging therapeutic strategies in the treatment of hemophilia A. Semin Thromb Hemost. 2017;43(6):581–590. 2016 K, K, H, S, Middeldorp S, S, L, D, S, L, to in with a of in to treatment in pregnant women with antiphospholipid or Semin Thromb Hemost. 2016 J, J, J, G, R. Circulating as thrombosis and Semin Thromb Hemost. 2016 oral in disease. Semin Thromb Hemost. 2017 I, platelet function Semin Thromb Hemost. 2017 E, K, extracellular in arterial and venous thrombosis. Semin Thromb Hemost. 2017 R, J, thrombotic purpura: a review of diagnosis and treatment in Semin Thromb Hemost. 2017 Favaloro or oral to bleeding risk a review of and Semin Thromb Hemost. 2018 M, for the factor mechanisms of current and emerging Semin Thromb Hemost. James 2018 H, as in an role and a new Semin Thromb Hemost. 2018 The current role of platelet function in clinical Semin Thromb Hemost. 2018 J, Sokol J, Simurda T, L, Z, D, Dobrotova M, J, Skornova I, Z, Kubisz P, Stasko of von Willebrand disease: current and Semin Thromb Hemost. 2018 T, M, I, P, J, Kubisz P, M. and on bleeding and Semin Thromb Hemost. 2018 The role of in and Semin Thromb Hemost. Elisa 2019 E, M, M, The role of in the of Semin Thromb Hemost. Ward 2019 Ward S, The of von Willebrand factor Semin Thromb Hemost. Jonathan 2019 J, L, C. and venous on that enable and assessment of the Semin Thromb Hemost. 2019 and to for Semin Thromb Hemost. 2019 B, K, M. Current in the management of women with von Willebrand disease. Semin Thromb Hemost. 2019 D, Rosendaal and the risk of venous thrombosis. Semin Thromb Hemost. 2020 therapies for bleeding in a for Semin Thromb Hemost. 2020 C, T, E, J, I, M, S, N, L, K, G, S, P, L, C, R, J, A, P, Venous thromboembolism in patients Semin Thromb Hemost. 2020 Effects of on hemostasis in patients with disease. Semin Thromb Hemost. Maria 2020 Favaloro Chen VM. of thrombosis in heparin-induced thrombocytopenia and immune thrombotic thrombocytopenia. Semin Thromb Hemost. 2021 de S, B, The thromboembolism status from to to in to and in clinical Semin Thromb Hemost. B. 2021 Fibrinolysis and are not the clinical of Semin Thromb Hemost. 2021 S. in and on disease. Semin Thromb Hemost. 2022 JP, in Semin Thromb Hemost. 2022 D, The role of in disease. Semin Thromb Hemost. 2022 to the Semin Thromb Hemost. a It be noted as a of the award, Eberhard F. Mammen Young Investigator are expected to a for publication in Seminars in Thrombosis and listing in this previous awardees to the journal and awardees as not their As with these awards, the current of winners a of various of their awardees are on their in or are in their and over into the of their be ([ Fig. 2 ]) is the of our award and is currently as a Senior with the of in and to as an presented a recent both presentations on the topic of von Willebrand disease his in and the in the on the and clinical of individuals with this interest in he is in basic and related to von Willebrand factor and Fig. 2 Young Investigator Award winner ([ Fig. ]) is another of the presented on the topic of and disease the recent European Congress in Thrombosis and Haemostasis and the de Investigator for is currently a the of in the between and coagulation in disease. in in in on the role in the of pediatric disease the for as a in began to the role of as an in current the in and to Fig. Young Investigator Award winner ([ Fig. ]) is the of our awardees and is currently presented the most recent Blood presentation and platelet awarded the for this is awarded for the best presentation by a young in the Thrombosis and Haemostasis of the Blood is a and Laboratory is the Haematology under the of to the role of in platelet and thrombosis Fig. Young Investigator Award winner ([ Fig. ]) presented his in the Scientific a recent American Society of Hematology of this in Blood and in the of Thrombosis and Haemostasis is currently an of the of North began as a mechanisms of venous thrombus the that is his the and the of North on mechanisms of thrombus formation. this he a interest in the of coagulation identifying the of factors and in venous thrombosis. As a he is currently a the of these Fig. Young Investigator Award winner ([ Fig. ]) two presentations a recent has published in with a of six the most recent two as first ] [ ] is currently in the of Hematology and of the of and in the of in the from the of and pediatric the in 2017 as a is of of Hematology and the of also an Eberhard F. Mammen Award in 2023 for a 2021 paper ] is the Thrombosis & Hemostasis of the of the Scientific on thrombosis and bleeding in pediatric patients with and acquired disease. Fig. Young Investigator Award winner ([ Fig. ]) is an and in the Australian for Blood in presented the 2023 abstract selected as of the of the meeting and selected for presentation in the Young Investigator Award is also a of the of of and the of and an in is also an of the “ Thrombosis of part of the of the and on the of the As a young and of is women in and a of the in for the Fig. Young Investigator Award winner award winners were to that selected to an Eberhard F. Mammen Young Investigator Award and the additional to be awarded an Eberhard F. Mammen Young Investigator would not possible the of many In would like to and James for their and also to all the in the in the and the in It is also to and all the patients with von Willebrand disease and von Willebrand factor in the and their we would not to insights into 1 and would like to the senior editorial team of Seminars in Thrombosis and Hemostasis for this ([ Fig. 2 ]) to selected for a 2023 Eberhard F. Mammen Young Investigator to to our on in a and would like to to the senior editorial team of Seminars in Thrombosis and Haemostasis for this would not possible the of and Dr the of our and from in the for to this to our understanding of and ([ Fig. ]) and to be for and awarded a 2023 Eberhard F. Mammen Young Investigator award the of our in the role of the platelet and platelet in and would like to the senior editorial of Seminars in Thrombosis and Hemostasis for this would not possible our and and the of would like to for and as well as of the Haematology award is a to in platelet and ([ Fig. ]) and to awarded a 2023 Eberhard F. Mammen Young Investigator to and that to the presented the Scientific of the American Society of Hematology that the of this award. to for his as to a new of to this to the senior editorial team of Seminars in Thrombosis and Hemostasis for this ([ Fig. ]) would like to to the Seminars in Thrombosis and Hemostasis senior editorial for for of the 2023 Eberhard E. Mammen Young Investigator Awards, on in pediatric and the of prothrombin in pediatric patients both presented the 2023 International Society on Thrombosis and Hemostasis The would not possible the and of Neil Goldenberg and the of our It is to be many clinical and in the fields of thrombosis and award to strategies to hemostasis in with ([ Fig. ]) to be selected as of the of the 2023 Eberhard F. Mammen Young Investigator Awards. would like to to the senior editorial of Seminars in Thrombosis and Hemostasis for the recognition of our that from patients with immune thrombotic thrombocytopenia increased potential and not which to the International Society of Fibrinolysis and Proteolysis meeting 2023 as a for the Young Investigator possible by from and a in research. also like to our and James for their contribution as well as from the of also to be in this list of and current young in thrombosis and to the of current and ([ Fig. ]) In with previous the Young Investigator from previous years as well as the outcome of their to as in [ Table 2 ]. The most recent arising publications are also in the list for the of the ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] mentioned times that most of the from earlier years in further some of these or the young of the Most awards (see [ Table 1 ] for a list of editorials on these to to the of the current and Young Investigator Award winners over are for Young Investigator and all awardees the best of to the by earlier award winners. Publication published 2024 Thieme New
No takes yet. Share an insight, caveat, or question.
Emmanuel J. Favaloro (2024) reported an editorial. This article is an editorial announcing the winners of the 2023 Eberhard F. Mammen Young Investigator Awards in thrombosis and hemostasis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: